Orvium unlocks the full potential of a decentralized, fair, transparent and competitive market free of biases, oligopolies and private interests. Scientific work is available from the moment it is submitted. Orvium establishes an independent, decentralized and immutable time-stamped proof of existence, authorship and ownership. Keeps in the blockchain a public trace of all the activity: submission, revisions, accepted and rejected peer reviews, copyright and user license changes, etc. Orvium is agnostic about licensing models by design. The model is always author's decision. Orvium empowers scientists to share the complete study by making available research data, code, etc. This increase scientific validation. Orvium integrates Big Data Analytics with the blockchain. This unlocks valuable insights to improve scientific production. Decentralized journals offer a low maintenance, highly flexible, cost effective and completely autonomous way to handle and categorize scientific literature while offering a further line of business for authors and editors. Orvium provides a collaborative framework for any single process related to the manuscript life cycle. Orvium opens the definition of journals, the creation of challenges to increase scientific validation and the promotion of patronage campaigns to the general public.
Phase 0 - Nebula
Phase 1 - Red Giant
Phase 2 - Supernova
Phase 3 - White Dwarf
Phase 4 - Neutron Star
Phase 5 - Pulsar
Attention. There is a risk that unverified members are not actually members of the team
$9 500 000
Advantages.1. Inefficiency in the field of academic papers and the existence of numerous intermediaries have long been questioned. Anyone who is engaged in academia can agree.2. A project developed by researchers from the European particle physics laboratory CERN. A powerful team member.3. It is different from other academic journal projects because it is focused on science and medical field.A complementary point1. It has a great weakness in marketing.2. The roadmap is not so fast.3. Recruitment of substantial participants is the most important issue.
"Positives ORV Tokens: The token is the primary currency that’s used on the platform. There is a transparent way to finance science and pay for the services. Users can get tokens for submitting their data, sharing data, and submit their manuscript for review. Journal Management: Journals that are published in the network that uses smart contracts to help manage it. This makes it easier for them to get them to produce high-quality journals towards other scientists in the network. Traceability: Orvium offers full traceability and allows users to select how their work is licensed and accessed by other users within the platform. The publications will have no delay, meaning that the journals will frequently be updated. As a result, this creates a collaborative environment. Negatives Limited Target Audience: Orvium is made only for people within the science industry. This can be difficult for the average investor to have interest in."
At Icon Partners, we think Orvium offers an interesting alternative to real-world issues that come with the current scientific article publishing process. The team and advisory board are really solid and can definitely deliver on the features mentioned in the whitepaper. Therefore, they are still far from the full release of the platform, which is always concerning when looking at ICOs. Finally, the fact that their token model includes a staking aspect will help reduce the velocity of ORV in the long run, increasing the demand for it, pushing its price upwards. We encourage you to do your own research and come to your own conclusions when investing in an ICO. All the information in this review are either facts or ICON Partners’ opinions and should not be used as investment advice.
Orvium is a platform that aims to target the scientific publishing industry.The platform reduces costs while empowering scientists and facilitates a more free market when compared to the current system.
Market Penetration Potential: The problem with the centralized nature of the current scientific publication system is outlined clearly. Orvium plans to address current market inefficiencies and with their focus on scientific publications, there is potential for the project to gain considerable market share.
Solution Advantage: Manuscripts will be submitted to the platform (with the option to stake ORV tokens) in order to create a proof-of-existence and authorship which is stored on the (Ethereum) blockchain. It is stated that “user licensing is completely determined by the authors or owner”. Compared to similar projects, Orvium is specifically targeting the scientific publication sector.
This offer is based on information provided solely by the offeror and other publicly available information. The token sale or exchange event is entirely unrelated to ICOholder and ICOholder has no involvement in it (including any technical support or promotion). Token sales listed from persons that ICOholder has no relationship with are shown only to help customers keep track of the activity taking place within the overall token sector. This information is not intended to amount to advice on which you should rely. You must obtain professional or specialist advice or carry out your own due diligence before taking, or refraining from, any action on the basis of the content on our site. Any terms and conditions entered into by contributors in respect of the acquisition of Tokens are between them and the issuer of the Token and ICOholder is not the seller of such Tokens. ICOholder has no legal responsibility for any representations made by third parties in respect of any Token sale and any claim for breach of contract must also be made directly against the Token issuing entity listed herein.
If you have any concerns about the nature, propriety or legality of this token sale or the persons involved in it please contact [email protected] with detailed information about your concerns.